These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8630634

  • 21. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
    Tavakoli M.
    Pharmacoeconomics; 2003; 21(6):443-54. PubMed ID: 12678570
    [Abstract] [Full Text] [Related]

  • 22. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
    Dougados M, Gueguen A, Nakache JP, Velicitat P, Veys EM, Zeidler H, Calin A.
    Rheumatology (Oxford); 1999 Mar; 38(3):235-44. PubMed ID: 10325662
    [Abstract] [Full Text] [Related]

  • 23. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
    Vidal L, Kneer W, Baturone M, Sigmund R.
    Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM, Bolten W, Burgos-Vargas R, Platt P, Nissilä M, Sahlberg D, Björneboe O, Baumgartner H, Valat JP, Franchimont P, Bluhmki E, Hanft G, Distel M.
    J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
    [Abstract] [Full Text] [Related]

  • 25. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
    Lipscomb GR, Wallis N, Armstrong G, Rees WD.
    Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
    Degner F, Sigmund R, Zeidler H.
    Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
    [Abstract] [Full Text] [Related]

  • 27. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P, Auleley GR, Ayral X, Marre JP, Amor B.
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [Abstract] [Full Text] [Related]

  • 28. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.
    Bevis PJ, Bird HA, Lapham G.
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():56-60. PubMed ID: 8630639
    [Abstract] [Full Text] [Related]

  • 29. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [Abstract] [Full Text] [Related]

  • 30. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S, Hall DB, Roszko PJ, Meloxicam Rheumatoid Arthritis Investigators.
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [Abstract] [Full Text] [Related]

  • 31. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L, Vélicitat P, Bluhmki E, Türck D, Scheuerer S, Combe B.
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs.
    Klein G, Kullich W, Schnitker J, Schwann H.
    Clin Exp Rheumatol; 2006 Mar; 24(1):25-30. PubMed ID: 16539815
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis.
    Prouse PJ, Bevis PJ, Bluhmki E, Distel M.
    Clin Ther; 1996 Mar; 18(3):429-39. PubMed ID: 8829018
    [Abstract] [Full Text] [Related]

  • 34. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea.
    de Mello NR, Baracat EC, Tomaz G, Bedone AJ, Camargos A, Barbosa IC, de Souza RN, Rumi DO, Martinez Alcala FO, Velasco JA, Cortes RJ.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):667-73. PubMed ID: 15225193
    [Abstract] [Full Text] [Related]

  • 35. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis.
    Moreau M, Dupuis J, Bonneau NH, Desnoyers M.
    Vet Rec; 2003 Mar 15; 152(11):323-9. PubMed ID: 12665145
    [Abstract] [Full Text] [Related]

  • 36. A double-blind, parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA, Hill J, Dixon JS, Looi D, Wright V.
    Curr Med Res Opin; 1985 Mar 15; 9(8):529-35. PubMed ID: 3896662
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT, West CR.
    Ann Rheum Dis; 2014 Sep 15; 73(9):1665-72. PubMed ID: 23852695
    [Abstract] [Full Text] [Related]

  • 39. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B, Vélicitat P, Garzón N, Bluhmki E.
    Inflamm Res; 2001 Mar 15; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [Abstract] [Full Text] [Related]

  • 40. Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration.
    Stei P, Kruss B, Wiegleb J, Trach V.
    Br J Rheumatol; 1996 Apr 15; 35 Suppl 1():44-50. PubMed ID: 8630637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.